Learn how the Mediterranean diet can help manage and even reverse MASH by supporting liver health, reducing inflammation, and ...

In a US retrospective study of data on veterans with compensated cirrhosis, more than half progressed to complications after approximately 5 years.

The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...

HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...

The AI-based AIM-NASH tool employs a machine learning model trained on more than 100,000 annotations from 59 pathologists.

Histoindex Pte Ltd. launched its laboratory-developed test for metabolic dysfunction-associated steatohepatitis (MASH), ...

Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...

Metabolic-dysfunction associated steatohepatitis (MASH) is a progressive and severe liver disease which is estimated to impact ... are described more fully in the “Risk Factors” section of Sagimet’s ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a polygenic disorder influenced by multiple genes, but their specific roles in the progression of disease remain unknown. To address this gap ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...

Researchers identify the Asah1 gene as a promising target for novel therapies to treat nonalcoholic fatty liver disease ...